quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:10·213d
SECFiling
HilleVax Inc. logo

SEC Form EFFECT filed by HilleVax Inc.

HLVX· HilleVax Inc.
Health Care
Original source

Companies

  • HLVX
    HilleVax Inc.
    Health Care

Recent analyst ratings

  • Jul 9UpdateLeerink Partners$2.00
  • Jul 9UpdateStifel$3.00
  • Jul 9UpdateH.C. Wainwright$2.00
  • Jul 8UpdateGuggenheim-
  • Jul 8UpdateJP Morgan$5.00
  • Dec 13UpdateH.C. Wainwright$28.00

Related

  • SEC206d
    SEC Form 15-12G filed by HilleVax Inc.
  • SEC213d
    SEC Form EFFECT filed by HilleVax Inc.
  • SEC216d
    Amendment: SEC Form SCHEDULE 13D/A filed by HilleVax Inc.
  • INSIDER216d
    SEC Form 4 filed by Large owner Takeda Pharmaceutical Co Ltd
  • SEC216d
    Amendment: SEC Form SCHEDULE 13D/A filed by HilleVax Inc.
  • SEC218d
    Amendment: SEC Form SCHEDULE 13D/A filed by HilleVax Inc.
  • INSIDER218d
    SEC Form 4 filed by Large owner Frazier Life Sciences X, L.P.
  • SEC218d
    SEC Form S-8 POS filed by HilleVax Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022